Investor holds 9.96% of DNA X common stock
DNA X, Inc. shareholder Laurence W. Lytton filed an amended Schedule 13G reporting a significant passive stake in the company’s common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
DNA X, Inc. shareholder Laurence W. Lytton filed an amended Schedule 13G reporting a significant passive stake in the company’s common stock. As of the event date, he beneficially owned 148,290 shares, representing 9.96% of the 1,488,268 shares outstanding.
Lytton reports sole voting and dispositive power over 109,402 shares and shared power over 38,888 shares. The filing notes additional warrants to purchase 22,222 shares are excluded because they are subject to a 4.99% beneficial ownership limitation. He certifies the holdings are not intended to change or influence control of DNA X, Inc.
AI-generated analysis. How Rhea-AI works. Not financial advice.